Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
Asia Pacific MedTech (BVI) Ltd Insider Profile
4 Followers
Asia Pacific MedTech (BVI) Ltd, Ten Percent Owner at Sorrento Therapeutics, holds 8.62M shares in Sorrento Therapeutics (Ticker: SRNEQ). Most recently, Asia Pacific MedTech (BVI) Ltd Sold $684,288 shares of Sorrento Therapeutics on Jan 25, 2018 for an estimated value of 5.17M.
Asia Pacific MedTech (BVI) Ltd Sorrento Therapeutics (SRNEQ)Ten Percent Owner
Sorrento Therapeutics (SRNEQ)
Ten Percent Owner
Ranked #18,701 out of 102,868 Corporate Insiders
Profitable Transactions
2 out of 2 Profitable Transactions
Average Return
+187.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Asia Pacific MedTech (BVI) Ltd's holdings
Insider Roles
Ten Percent Owner
Roles that Asia Pacific MedTech (BVI) Ltd holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:May 03, 2017 - May 03, 2018
Return:+305.20%
The most profitable trade made by Asia Pacific MedTech (BVI) Ltd
Asia Pacific MedTech (BVI) Ltd's Trading History
List of latest transactions for each holding click on a transaction to see Asia Pacific MedTech (BVI) Ltd's performance on stock
You May Also Like
Asia Pacific MedTech (BVI) Ltd insider profile FAQ
What is the percentage of profitable transactions made by Asia Pacific MedTech (BVI) Ltd?
The percentage of profitable transactions made by Asia Pacific MedTech (BVI) Ltd is 100%.
What is the average return per transaction made by Asia Pacific MedTech (BVI) Ltd?
The average return per transaction made by Asia Pacific MedTech (BVI) Ltd is 187.20%.
What stocks does Asia Pacific MedTech (BVI) Ltd hold?
Asia Pacific MedTech (BVI) Ltd holds: SRNEQ stocks.
What was Asia Pacific MedTech (BVI) Ltd’s latest transaction?
Asia Pacific MedTech (BVI) Ltd latest transaction was an Informative Sell of $5.17M.
What was Asia Pacific MedTech (BVI) Ltd's most profitable transaction?
Asia Pacific MedTech (BVI) Ltd’s most profitable transaction was an Informative Buy of SRNEQ stock on May 3, 2017. The return on the trade was 305.20%.
What is Asia Pacific MedTech (BVI) Ltd's role in Sorrento Therapeutics?
Asia Pacific MedTech (BVI) Ltd's role in Sorrento Therapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.